Health CareMedical Equipment and Services
  • Price (JPY)2,255.00
  • Today's Change21.00 / 0.94%
  • Shares traded3.06m
  • 1 Year change-2.13%
  • Beta0.9599
Data delayed at least 20 minutes, as of Mar 27 2023 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, science, video and other products. The Company operates in five business segments. The Endoscopy segment provides gastrointestinal endoscopy, surgical endoscopy, endoscopy systems and repair services. The Therapeutic Equipment segment provides endoscopic treatment tools, energy devices, urology, gynecology and otolaryngology products. The Scientific segment provides biological microscope, industrial microscope, industrial endoscope and non-destructive inspection equipment. The Imaging segment provides digital cameras and recording machines. The Others segment is engaged in the manufacture and sale of biomaterials. The Company is also engaged in the financial investment business.

  • Revenue in JPY (TTM)880.66bn
  • Net income in JPY133.54bn
  • Incorporated1919
  • Employees31.56k
  • Location
    Olympus CorpShinjuku Monolith, 2-3-1, Nishi-ShinjukuSHINJUKU-KU 163-0914JapanJPN
  • Phone+81 333402111
  • Fax+81 333402062
  • Websitehttps://www.olympus.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
7733:TYO since
Taewoong Medical Co LtdAnnounced24 Feb 202324 Feb 2023Announced-0.40%370.00m
Data delayed at least 20 minutes, as of Mar 27 2023 07:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
ASAHI INTECC CO., LTD.85.48bn11.95bn600.04bn10.44k50.224.8729.757.0243.9843.98314.70453.730.56971.185.748,191,759.008.0510.839.2612.7065.6367.6714.1416.972.68--0.098527.0326.4112.738.747.0411.919.55
MicroPort Scientific Corp104.43bn-50.23bn616.76bn9.19k--3.81--5.91-1.67-1.673.465.310.2121.094.91782,113.10-13.00-5.78-18.10-8.5661.5668.39-61.31-15.303.14-38.300.4091--20.0214.83-44.57--34.78--
Shandong Weigao Group Medical Polymer Co266.38bn47.81bn937.61bn11.48k19.382.3714.003.520.63580.63583.545.190.44433.792.601,438,283.008.697.9411.389.7951.3859.0219.5618.662.6743.690.166829.5313.1618.547.5717.5312.4510.10
Fisher & Paykel Healthcare Corporatn Ltd119.37bn20.35bn1.23tn7.38k60.4810.2245.0010.290.43250.43252.542.560.71131.666.77199,633.9012.1321.9514.5226.9861.0164.5917.0522.790.882826.390.101947.97-14.6913.46-28.1017.3821.9415.16
Cochlear Limited148.79bn22.71bn1.29tn4.50k56.848.6643.698.683.973.9726.0426.080.69931.614.83380,622.2010.679.7012.8912.8875.4674.7015.2612.492.2246.410.127490.6310.065.62-11.455.271.67-1.25
Shanghai United Img Hlthcare Co Ltd160.73bn29.41bn2.44tn5.48k89.527.69347.5015.211.741.7410.1620.27------1,541,505.00--------45.69--18.06--3.19--0.0289--25.91--56.96------
Terumo Corp797.81bn87.30bn2.58tn28.29k29.762.3916.603.23115.88115.881,057.781,442.010.54181.845.5528,197,250.005.936.986.828.2951.2553.8010.9413.451.7378.780.177525.1914.576.4714.9410.0613.9310.12
FUJIFILM Holdings Corp2.76tn207.73bn2.69tn75.47k12.520.96457.750.9738517.54517.546,874.066,718.770.70083.014.8036,557,370.005.204.686.706.1539.5240.547.416.901.22160.810.149323.6715.201.7016.549.9411.349.46
Olympus Corp880.66bn133.54bn2.87tn31.56k21.304.6614.173.26104.88107.05691.53479.520.65581.705.2727,906,800.009.965.8313.418.3667.4064.4015.197.811.55356.830.368121.4618.933.2576.4422.020.513914.87
Data as of Mar 27 2023. Currency figures normalised to Olympus Corp's reporting currency: Japanese Yen JPY

Institutional shareholders

31.99%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 28 Feb 202379.08m6.15%
Baillie Gifford & Co.as of 30 Jun 202165.60m5.10%
Capital Research & Management Co. (World Investors)as of 31 Dec 202253.68m4.18%
Nikko Asset Management Co., Ltd.as of 03 Mar 202339.30m3.06%
Daiwa Asset Management Co. Ltd.as of 28 Feb 202337.03m2.88%
BlackRock Fund Advisorsas of 31 Oct 202236.93m2.87%
The Vanguard Group, Inc.as of 03 Mar 202333.03m2.57%
BlackRock Japan Co., Ltd.as of 31 Oct 202226.96m2.10%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 23 Jan 202320.19m1.57%
Capital International Ltd.as of 02 Mar 202319.59m1.52%
More ▼
Data from 31 Dec 2022 - 31 Dec 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.